PHVS
Pharvaris N.V. Ordinary Shares
Nasdaq · usd
Pharvaris N.V. Ordinary Shares (PHVS) trades at $31.77 (+1.15%) as of 2:24:13 PM EDT on Oct 26, 2026, -0.81% over the past month. Market cap is $2.21B, with 2.8 days to cover in short interest.
Stock performance
How Pharvaris N.V. Ordinary Shares (PHVS) stock has performed from one day to one year, with its 52-week range.
- 1D
- +1.11%
- 1W
- +6.68%
- 1M
- -0.81%
- YTD
- +14.45%
- 1Y
- +39.18%
- 52-wk range
- $21.02 – $43.25
Key statistics
Today's trading snapshot for PHVS: day range, open, previous close, volume and market cap.
- Day range
- $31.30 – $32.08
- Open
- $31.38
- Prev close
- $31.41
- Volume
- 150.04K
- Market cap
- $2.21B
- Shares out
- 65.41M
PHVS short interest
How heavily PHVS is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.8
- Short interest
- 2.01M
- Avg volume
- 707.99K
As of · reported to FINRA twice monthly.
PHVS news
The latest news and headlines about Pharvaris N.V. Ordinary Shares (PHVS).
- Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The LancetpositiveGlobeNewswire Inc.· Oct 8, 2026
- Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in TherapypositiveGlobeNewswire Inc.· Oct 5, 2026
- Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in ImmunologypositiveGlobeNewswire Inc.· Aug 6, 2026
- After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?neutralThe Motley Fool· Jul 24, 2026
- Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary SharespositiveGlobeNewswire Inc.· May 8, 2026
Frequently asked questions
What is the Pharvaris N.V. Ordinary Shares (PHVS) stock price today?
Pharvaris N.V. Ordinary Shares (PHVS) is trading at $31.77 (+1.15% on the day) as of 2:24:13 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Pharvaris N.V. Ordinary Shares?
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both…
What is the short interest in PHVS?
As of Sep 30, 2026, PHVS has 2.01M shares short and 2.8 days to cover.
What exchange is PHVS listed on?
Pharvaris N.V. Ordinary Shares (PHVS) trades on Nasdaq in USD.
Build with AI
Build an analysis of PHVS with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PHVS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.